Literature DB >> 25411951

A pilot study of autofluorescence in the diagnosis of pleural disease.

Feng Wang1, Zhen Wang1, Zhaohui Tong2, Lili Xu1, Xiaojuan Wang1, Yanbing Wu1.   

Abstract

BACKGROUND: Conventional medical thoracoscopy (MT), routinely performed in patients with pleural disease, does not always lead to a conclusive diagnosis. The endoscopic appearance of pleural diseases under white light could be misleading. Autofluorescence has been shown to be an interesting and effective diagnostic tool. The objective of this study was to evaluate the diagnostic value of autofluorescence imaging during MT.
METHODS: Patients with undiagnosed pleural effusion admitted to our clinical center between August 2013 and February 2014 were enrolled. MT was performed first with white light and then by autofluorescence. Endoscopic results of different diseases were recorded, and biopsy specimens were obtained for pathologic analysis. We calculated the diagnostic sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the two methods by comparing them with the pathologic results.
RESULTS: Thirty-seven eligible patients were studied, including 21 with malignancy, nine with tuberculous pleurisy, three with infective pleurisy, and four with no diagnosed condition. Autofluorescence revealed additional malignant lesions, which were missed under white light in five patients. The diagnostic sensitivity and NPV of autofluorescence were 100% (95% CI, 98.5%-100%) and 100% (95% CI, 93.9%-100%), respectively. Autofluorescence was superior to white light, with a sensitivity of 92.8% (95% CI, 89.3%-95.3%) and NPV of 76.8% (95% CI, 67.0%-84.4%). For the specificity and PPV, no significant difference was found.
CONCLUSIONS: The advantage of autofluorescence is its high sensitivity and NPV. It is useful to detect microlesions and delineate the pathologic margins. Autofluorescence can benefit patients with its better visualization.

Entities:  

Mesh:

Year:  2015        PMID: 25411951     DOI: 10.1378/chest.14-1351

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  Medical thoracoscopy in China-the present status and the future.

Authors:  Jing-Yuan Liu; Liang Xiong; Min Zhang; Shi-Yuan Shuai; Xiao-Shan Wei; Lin-Lin Ye; Qiong Zhou
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

Review 2.  Medical thoracoscopy and its evolving role in the diagnosis and treatment of pleural disease.

Authors:  Vivek Murthy; Jamie L Bessich
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

3.  Metabolic characteristics of large and small extracellular vesicles from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.

Authors:  Ping Luo; Kaimin Mao; Juanjuan Xu; Feng Wu; Xuan Wang; Sufei Wang; Mei Zhou; Limin Duan; Qi Tan; Guangzhou Ma; Guanghai Yang; Ronghui Du; Hai Huang; Qi Huang; Yumei Li; Mengfei Guo; Yang Jin
Journal:  J Extracell Vesicles       Date:  2020-07-14

4.  Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.

Authors:  Lisha Luo; Shuanglinzi Deng; Wei Tang; Xinyue Hu; Feifei Yin; Huan Ge; Jiale Tang; Zhonghua Liao; Juntao Feng; Xiaozhao Li; Biwen Mo
Journal:  J Clin Lab Anal       Date:  2022-07-12       Impact factor: 3.124

5.  Improved heart hemodynamics after draining large-volume pleural effusion: a prospective cohort study.

Authors:  Zheng Wang; Qi-Zhe Cai; Cheng-Jun Ban; Duo Chen; Li-Li Xu; Xiao-Juan Wang; Zhen Wang; Yuan Yang; Xiu-Zhang Lv; Huan-Zhong Shi
Journal:  BMC Pulm Med       Date:  2018-04-25       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.